Download PDF

Register to download the report. Already a member?

Sign Up


71729 1526457625HCLS_ECUADOR_Final.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:


Orlando Oliveira – SVP and General Manager International, TESARO, Switzerland

03.03.2017 / Pharmaboardroom

Orlando Oliviera, SVP & GM International, TesaroWell-funded and with a stellar pipeline, TESARO is an up and coming Boston-based oncology biotech ready to launch their two first products in the European market in 2017.

Orlando, we understand your background in the biotech industry is with Amgen. After a career with the biggest of the biotechs, what was it that convinced you to join TESARO?

My first position after leaving Amgen was with another Boston-based biotech called Cubist Pharmaceuticals, and I was part of a great project which was to build an international infrastructure for the business here in Europe. Cubist was acquired by MSD in 2015, so it was a short but successful ride. After this experience, I really felt how empowering it was to work for a smaller biotech, where you can really see the impact that you have on the organization each day.



Most Read

Download PDF

First Name:

Last Name: